CAS 1242137-15-0

Enzalutamide Carboxylic Acid Metabolite (M1)

CAS : 1242137-15-0

Formule : C₂₀H₁₃F₄N₃O₃S

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 451.3941

Ref: IN-DA00A19I

Enzalutamide carboxylic acid

CAS : 1242137-15-0

Enzalutamide carboxylic acid

Degré de pureté : ≥95%

Masse moléculaire : 451.39g/mol

Ref: 54-BUP04884

4-(3-(4-Cyano-3-(Trifluoromethyl)Phenyl)-5,5-Dimethyl-4-Oxo-2-Thioxoimidazolidin-1-Yl)-2-Fluorobenzoic Acid

CAS : 1242137-15-0

4-(3-(4-Cyano-3-(Trifluoromethyl)Phenyl)-5,5-Dimethyl-4-Oxo-2-Thioxoimidazolidin-1-Yl)-2-Fluorobenzoic Acid

Degré de pureté : 98%

Masse moléculaire : 451.39g/mol

Ref: 54-PC108485

Enzalutamide Carboxylic Acid Metabolite (M1)

CAS : 1242137-15-0

Formule : C₂₀H₁₃F₄N₃O₃S

Couleur et forme : White To Off-White Solid

Masse moléculaire : 451.40

Ref: 4Z-E-068005

Enzalutamide carboxylic acid

CAS : 1242137-15-0

Enzalutamide carboxylic acid is an antagonist of androgen receptor (AR) .

Formule : C₂₀H₁₃F₄N₃O₃S

Degré de pureté : 97.88%

Couleur et forme : Solid

Masse moléculaire : 451.39

Ref: TM-T8217

Enzalutamide Carboxylic Acid

CAS : 1242137-15-0

Applications Enzalutamide Carboxylic Acid is used as hormone therapies to prevent androgen-fuled growth of castrate-resistant prostate cancer.
References Tomasz, M.B., et al.: New Engl, J. Med., 424, 371 (2014);

Formule : C₂₀H₁₃F₄N₃O₃S

Couleur et forme : Neat

Masse moléculaire : 451.39

Ref: TR-E559800

Enzalutamide carboxylic acid

CAS : 1242137-15-0

Degré de pureté : 98%

Masse moléculaire : 451.3999939

Ref: 10-F843830

Enzalutamide Carboxylic Acid

CAS : 1242137-15-0

Enzalutamide Carboxylic Acid is a potent n-oxide derivative of Enzalutamide, which is used in the treatment of metastatic castration-resistant prostate cancer. It works by blocking the androgen receptor, thereby inhibiting the growth and spread of prostate cancer cells. Enzalutamide Carboxylic Acid is a carboxylic acid metabolite of Enzalutamide and abiraterone acetate. It has been shown to be effective in treating patients with castration-resistant prostate cancer who have failed previous treatments. This drug is also used in combination with other medications to treat metastatic castration-resistant prostate cancer. Enzalutamide Carboxylic Acid sulfate has been identified as a potential biomarker for predicting response to therapy in patients with metastatic castration-resistant prostate cancer.

Formule : C₂₀H₁₃F₄N₃O₃S

Degré de pureté : Min. 95%

Masse moléculaire : 451.39 g/mol

Ref: 3D-SZB13715

Enzalutamide Carboxylic Acid Impurity

CAS : 1242137-15-0

Formule : C₂₀H₁₃F₄N₃O₃S

Masse moléculaire : 451.4

Ref: ST-EA-CP-E16007